NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

病患監測設備的全球市場 - 預測(2021年∼2026年)

Global Patient Monitoring Devices Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023182
出版日期 內容資訊 英文 113 Pages
商品交期: 最快1-2個工作天內
價格
病患監測設備的全球市場 - 預測(2021年∼2026年) Global Patient Monitoring Devices Market - Forecasts from 2021 to 2026
出版日期: 2021年07月07日內容資訊: 英文 113 Pages
簡介

全球病患監測設備的市場規模,2019年價值191億9700萬美元,預計以5.88%的年複合成長率成長2026年達到286億3000萬美元。

心臟監測、呼吸監測、神經監測、分娩監測是不同類型的醫療參數監測,推動了對監測設備的需求。全球人口老齡化、生活方式疾病增加以及家庭患者監測的進步是推動這一市場的一些因素。然而,已開發國家的飽和和低效的報銷規定可能會損害市場成長。人口老齡化和生活方式疾病正在推動美洲和歐洲地區的患者設備監測市場,而亞太地區可支配收入增加和人口成長將在未來六年增加該地區對患者監測設備的需求。

本報告提供全球病患監測設備市場調查,市場概要和競爭狀態,各設備類型、各地區的市場分析,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 終端用戶的交易
    • 購買企業的交易
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的競爭關係
  • 產業的價值鏈分析

第5章 各類型:病患監測設備的市場分析

  • 簡介
  • 血液循環動態監測設備
  • 多參數監視設備
  • 遙控病患監測設備
  • 手術中神經監測設備
  • 體重監視設備
  • 呼吸監測設備
  • 溫度監測設備
  • 心電圖監視器
  • 胎兒、新生兒的監測設備

第6章 各地區:病患監測設備的市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第7章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,共同開發
  • 供應商競爭力 矩陣

第8章 企業簡介

  • General Electric Company (GE Healthcare)
  • Johnson & Johnson
  • Masimo Corporation
  • Medtronic Care Management Services LLC
  • Omron Corporation
  • Koninklijke Philips NV
  • Siemens Healthcare GmbH
  • Abbott Laboratories
  • Baxter International Inc.
目錄
Product Code: KSI061610461

The global patient monitoring devices market is evaluated at US$19.197 billion for the year 2019 growing at a CAGR of 5.88% reaching a market size of US$28.630 billion by the year 2026. Monitoring in medical usage is a term that refers to the inspection of a disease, condition on one or several medical parameters over time. It is carried out by constantly measuring parameters by either employing a medical monitor such as continuously measuring vital signs by a bedside monitor or by repeatedly performing medical tests such as blood glucose monitoring with a glucose meter in people with diabetes mellitus. Patient equipment monitoring devices are manufactured by assembling sensors, a display device, translators, and communication links. Cardiac monitoring, Respiratory monitoring, Neurological monitoring, Childbirth monitoring are different types of healthcare parameters monitoring, boosting the demand for monitoring devices. The aging population globally, increasing occurrences of lifestyle diseases, and advancement in-home patient monitoring are some factors driving this market. However, saturation in developed countries and inefficient reimbursement regulations may impair market growth. Aging population and lifestyle diseases are driving the patient equipment monitoring market in the Americas and the European region while increasing disposable income and population growth in APAC will augment the demand for patient monitoring devices in the region over the next six years.

The market has been significantly driven by the increasing health expenditures done by several governments to enhance the technological advancements in the sector.

The advent of COVID-19 had a positive impact on the patient monitoring devices market. Globally, the COVID-19 pandemic showed enormous pressure on the healthcare system and hospitals that were understaffed and overworked. Patient Monitoring devices such as ventilators helped in the monitoring of critically ill COVID-19 patients which allows the measurements of physiological reserves and indicates the effectiveness of therapeutic interventions during the pandemic which shows the positive impact on the market. Furthermore, the companies are increasing their manufacturing of critical/essential medical device products. For instance, in March 2020, Royal Philips ramped up the production of certain critical care products and solutions which help in detecting and providing treatment for patients with COVID-19. The product line includes the patient vital signs monitors, medical consumables for non-invasive and invasive ventilation, and portable ventilators to treat respiratory conditions. Thus, owing to the aforementioned factors the market is likely to have a positive impact from the pandemic on it.

Increasing cases of chronic diseases at a global will drive the market during the forecast period.

As per the World Health Organization 2020, the major chronic disorders such as cancer, chronic obstructive pulmonary disease, cardiovascular diseases (CVD), and diabetes were estimated to account for 73% of all deaths and 60% of the global burden of diseases in 2020. Also, according to Globocan 2020, the new cancer cases that were diagnosed accounted for 19,292,789 in 2020 worldwide, with 9,958,133 deaths due to cancers globally. Among all cancers, breast cancer accounted to 2,261, 419 new cancer cases, followed by lung (2,206,771), Prostate (1,414,259) and colon (1,148,515) new cases in 2020. Here, patient monitoring technologies come into play and identify small changes in the patient's physiological data, hence promoting self-monitoring. Thus, it reduces readmissions and prevents avoidable hospitalizations, decreases the number of unnecessary trips to the doctor's office, and reduces travel-related expenses. On a short- and long-term basis, by the proper implementation, patient monitoring technologies can expand access to quality healthcare and save time and money.

The demand for patient monitoring devices increased during the pandemic due to increasing concerns about cardio-related impacts of the disease and the trend is expected to continue in the coming years.

Amid pandemic, the virus poses a particular risk to people who have underlying medical conditions, including Cardiovascular disease and Hypertension. In 2020, the World Health Foundation, a study was conducted in JAMA Cardiology among 100 COVID-19 patients whereas 60 showed some signs of cardiovascular disorders. Also, in 2020, doctors at Edinburgh University examined echocardiograms from more than 1,200 COVID-19 patients across 69 countries and found cardiac problems in 55% whereas 1 in 7 exhibiting signs of severe abnormalities. This has led hospitals to implement a patient monitoring system to keep track of a patient's health, thereby positively influencing the verticle growth.

Furthermore, the market players in the cardiac monitoring space are actively advancing the product technologies and increasing the adoption of these devices, thus, it is likely to fuel the growth of this segment. For example, in 2018, Qardio Inc. received approval from Australia's Therapeutic Goods Administration (TGA) for QardioCore, its revolutionary ECG monitor. Similarly, in August 2019, AliveCor launched the KardiaMobile 6L in the United Kingdom, the world's first FDA-cleared and CE-marked, six-lead personal heart monitoring device. This unique, smartphone-based technology provides a multi-dimensional view of the heart in 30-seconds, including visibility into arrhythmias, such as atrial fibrillation (AF), that are leading indicators of cardiovascular disease. Therefore, the overall scenario of the cardiac application in the market studied is expected to witness significant growth over the forecast period.

Market Segmentation:

  • By Type

Hemodynamic Monitoring Devices

Multiparameter Monitoring Devices

Remote Patient Monitoring Devices

Neuromonitoring Devices

Weight Monitoring Devices

Respiratory Monitoring Devices

Temperature Monitoring Devices

Cardiac Monitoring Devices

Fetal & Neonatal Monitoring Devices

Respiratory Monitoring Devices

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Patient Monitoring Devices Market Analysis, by Type

  • 5.1. Introduction
  • 5.2. Hemodynamic Monitoring Devices
  • 5.3. Multiparameter Monitoring Devices
  • 5.4. Remote Patient Monitoring Devices
  • 5.5. Neuromonitoring Devices
  • 5.6. Weight Monitoring Devices
  • 5.7. Respiratory Monitoring Devices
  • 5.8. Temperature Monitoring Devices
  • 5.9. Cardiac Monitoring Devices
  • 5.10. Fetal & Neonatal Monitoring Devices
  • 5.11. Respiratory Monitoring Devices

6. Patient Monitoring Devices Market Analysis, by Geography

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. USA
    • 6.2.2. Canada
    • 6.2.3. Mexico
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
    • 6.3.3. Others
  • 6.4. Europe
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. UK
    • 6.4.4. Others
  • 6.5. Middle East and Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. Others
  • 6.6. Asia Pacific
    • 6.6.1. China
    • 6.6.2. India
    • 6.6.3. Japan
    • 6.6.4. South Korea
    • 6.6.5. Taiwan
    • 6.6.6. Thailand
    • 6.6.7. Indonesia
    • 6.6.8. Others

7. Competitive Environment and Analysis

  • 7.1. Major Players and Strategy Analysis
  • 7.2. Emerging Players and Market Lucrativeness
  • 7.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 7.4. Vendor Competitiveness Matrix

8. Company Profiles

  • 8.1. General Electric Company (GE Healthcare)
  • 8.2. Johnson & Johnson
  • 8.3. Masimo Corporation
  • 8.4. Medtronic Care Management Services LLC
  • 8.5. Omron Corporation
  • 8.6. Koninklijke Philips NV
  • 8.7. Siemens Healthcare GmbH
  • 8.8. Abbott Laboratories
  • 8.9. Baxter International Inc.